Intra-Cellular Therapies
ITCI
#1534
Rank
S$18.07 B
Marketcap
S$169.69
Share price
0.00%
Change (1 day)
81.32%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Last known market cap: S$18.07 Billion

As of January 2026 Intra-Cellular Therapies has a market cap of S$18.07 Billion. This makes Intra-Cellular Therapies the world's 1534th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025S$18.03 B47.5%
2024S$12.22 B34.32%
2023S$9.10 B35.49%
2022S$6.71 B16.56%
2021S$5.76 B70.29%
2020S$3.38 B31.84%
2019S$2.56 B200.58%
2018S$0.85 B-19.19%
2017S$1.05 B11.86%
2016S$0.94 B-71.22%
2015S$3.28 B377.29%
2014S$0.68 B22.52%
2013S$0.56 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MediciNova
MNOV
S$96.12 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S$13.75 M-99.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$1.27 B-92.94%๐Ÿ‡บ๐Ÿ‡ธ USA